Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Balance Sheet Related Disclosures [Abstract] | ||
| Prepaid clinical trial | $ 1,832 | $ 1,112 |
| Prepaid research and development | 926 | 841 |
| Prepaid insurance | 232 | 249 |
| Deferred offering costs | 140 | 135 |
| Other | 536 | 308 |
| Total prepaid expenses and other current assets | $ 3,666 | $ 2,645 |
| X | ||||||||||
- Definition Prepaid clinical trial. No definition available.
|
| X | ||||||||||
- Definition Prepaid research and development contracts. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current assets classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|